Clement A., Christensen S.L., Jansen-Olesen I., Olesen J., Guo S. 2023. The ATP sensitive potassium channel (KATP) is a novel target for migraine drug development. Front. Mol. Neurosci. 16, 1182515. https://doi.org/10.3389/fnmol.2023.1182515
Article PubMed PubMed Central CAS Google Scholar
Ferrari M.D., Goadsby P.J., Burstein R., Kurth T., Ayata C., Charles A., Ashina M., van den Maagdenberg A.M.J.M., Dodick D.W. 2022. Migraine. Nat. Rev. Dis. Primers. 8, 1–20. https://doi.org/10.1038/s41572-021-00328-4
Davidsson O.B., Olofsson I.A., Kogelman L.J., Andersen M.A., Rostgaard K., Hjalgrim H., Olesen J., Hansen T.F. 2021. Twenty-five years of triptans – a nationwide population study. Cephalalgia. 41 (8), 894–904. https://doi.org/10.1177/0333102421991809
Clement A., Guo S., Jansen-Olesen I., Christensen S.L. 2022. ATP-sensitive potassium channels in migraine: Translational findings and therapeutic potential. Cells. 11 (5), 2406. https://doi.org/10.3390/cells11152406
Article PubMed PubMed Central CAS Google Scholar
Moskowitz M.A., Reinhard J.F., Romero J., Melamed E., Pettibone D.J. 1979. Neurotransmitters and the fifth cranial nerve: Is there a relation to the headache phase of migraine? Lancet. 314 (8148), 883–885. https://doi.org/10.1016/s0140-6736(79)92692-8
Ashina M., Hansen J.M., Do T.P., Melo-Carrillo A., Burstein R., Moskowitz M.A. 2019. Migraine and the trigeminovascular system—40 years and counting. Lancet Neurol. 18 (8), 795–804. https://doi.org/10.1016/S1474-4422(19)30185-1
Article PubMed PubMed Central Google Scholar
Nitti M., Piras S., Brondolo L., Marinari U.M., Pronzato M.A., Furfaro AL. 2018. Heme oxygenase 1 in the nervous system: Does it favor neuronal cell survival or induce neurodegeneration? Inter. J. Mol. Sci. 19 (8), 2260. https://doi.org/10.3390/ijms19082260
Intagliata S., Salerno L., Ciaffaglione V., Leonardi C., Fallica A.N., Carota G., Amata E., Marrazzo A., Pittalà V., Romeo G. 2019. Heme oxygenase-2 (HO-2) as a therapeutic target: Activators and inhibitors. Eur. J. Med. Chem. 183, 111703. https://doi.org/10.1016/j.ejmech.2019.111703
Article PubMed CAS Google Scholar
Arngrim N., Schytz H.W., Hauge M.K., Ashina M., Olesen J. 2014 Carbon monoxide may be an important molecule in migraine and other headaches. Cephalalgia. 34 (14), 1169–1180. https://doi.org/10.1177/0333102414534085
Arngrim N., Schytz H.W., Britze J., Vestergaard M.B., Sander M., Olsen K.S., Olesen J., Ashina M. 2018. Carbon monoxide inhalation induces headache in a human headache model. Cephalalgia. 38 (4), 697–706. https://doi.org/10.1177/0333102417708768
Cazuza R.A., Batallé G., Bai X., Leite-Panissi C.R.A., Pol O. 2022. Effects of treatment with a carbon monoxide donor and an activator of heme oxygenase 1 on the nociceptive, apoptotic and/or oxidative alterations induced by persistent inflammatory pain in the central nervous system of mice. Brain Res. Bull. 188, 169–178. https://doi.org/10.1016/j.brainresbull.2022.08.004
Article PubMed CAS Google Scholar
Hervera A., Leánez S., Negrete R., Motterlini R., Pol O. 2012. Carbon monoxide reduces neuropathic pain and spinal microglial activation by inhibiting nitric oxide synthesis in mice. PLoS ONE. 7 (8), e43693. https://doi.org/10.1371/journal.pone.0043693
Article PubMed PubMed Central CAS Google Scholar
Moreno P., Cazuza R.A., Mendes-Gomes J., Díaz A.F., Polo S., Leánez S., Leite-Panissi C.R.A., Pol O. 2019. The effects of cobalt protoporphyrin IX and tricarbonyldichlororuthenium (II) dimer treatments and its interaction with nitric oxide in the locus coeruleus of mice with peripheral inflammation. Int. J. Mol. Sci. 20 (9), 2211. https://doi.org/10.3390/ijms20092211
Article PubMed PubMed Central CAS Google Scholar
Steiner A.A., Branco L.G., Cunha F.Q., Ferreira S.H. 2001. Role of the haeme oxygenase/carbon monoxide pathway in mechanical nociceptor hypersensitivity. Br. J. Pharmacol. 132 (8), 1673–1682. https://doi.org/10.1038/sj.bjp.0704014
Article PubMed PubMed Central CAS Google Scholar
Kanellopoulos J.M., Almeida-da-Silva C.L.C., Rüütel Boudinot S., Ojcius D.M., 2021 Structural and functional features of the P2X4 receptor: An immunological perspective. Front. Immunol. 12, 645834. https://doi.org/10.3389/fimmu.2021.645834
Article PubMed PubMed Central CAS Google Scholar
Burnstock G. 2007. Physiology and pathophysiology of purinergic neurotransmission. Physiol. Rev. 87, 659–797. https://doi.org/10.1152/physrev.00043.2006
Article PubMed CAS Google Scholar
Wilkinson W., Gadeberg H., Harrison A., Allen N., Riccardi D., Kemp P. 2009. Carbon monoxide is a rapid modulator of recombinant and native P2X2 ligand-gated ion channels. Br. J. Pharmacol. 158 (3), 862–871. https://doi.org/10.1111/j.1476-5381.2009.00354.x
Article PubMed PubMed Central CAS Google Scholar
Wilkinson W.J., Kemp P.J. 2011. The carbon monoxide donor, CORM-2, is an antagonist of ATP-gated, human P2X4 receptors. Purinerg. Signal. 7, 57–64. https://doi.org/10.1007/s11302-010-9213-8
Zakharov A., Vitale C., Kilinc E., Koroleva K., Fayuk D., Shelukhina I., Naumenko N., Skorinkin A., Khazipov R., Giniatullin R. 2015. Hunting for origins of migraine pain: Cluster analysis of spontaneous and capsaicin-induced firing in meningeal trigeminal nerve fibers. Front. Cell. Neurosci. 9, 287. https://doi.org/10.3389/fncel.2015.00287
Article PubMed PubMed Central CAS Google Scholar
Guo S., Olesen J., Ashina M. 2014. Phosphodiesterase 3 inhibitor cilostazol induces migraine-like attacks via cyclic AMP increase. Brain. 137 (11), 2951–2959. https://doi.org/10.1093/brain/awu244
Edvinsson J.C.A., Viganò A., Alekseeva A., Alieva E., Arruda R., De Luca C., D’Ettore N., Frattale I., Kurnukhina M., Macerola N., Malenkova E., Maiorova M., Novikova A., Řehulka P., Rapaccini V., Roshchina O., Vanderschueren G., Zvaune L., Andreou A.P., Haanes K.A. 2020. European Headache Federation School of Advanced Studies (EHF-SAS). The fifth cranial nerve in headaches. J. Headache Pain. 21, 65. https://doi.org/10.1186/s10194-020-01134-1
Article PubMed PubMed Central CAS Google Scholar
Olesen J. 2008. The role of nitric oxide (NO) in migraine, tension-type headache and cluster headache. Pharmacol. Ther. 120 (2), 157–171. https://doi.org/10.1016/j.pharmthera.2008.08.003
Article PubMed CAS Google Scholar
Li X., Clark J.D. 2002. Spinal cord heme oxygenase participates in glutamate-induced pain-related behaviors. Eur. J. Pharmacol. 450 (1), 43–48. https://doi.org/10.1016/s0014-2999(02)02051-4
Article PubMed CAS Google Scholar
Morita T., Perrella M.A., Lee M.E., Kourembanas S. 1995. Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP. Proc. Natl. Acad. Sci. USA. 92 (5), 1475–1479. https://doi.org/10.1073/pnas.92.5.1475
Article PubMed PubMed Central CAS Google Scholar
Bernier L.-P., Ase A.R., Séguéla P. 2018. P2X receptor channels in chronic pain pathways. Br. J. Pharmacol. 175 (12), 2219–2230. https://doi.org/10.1111/bph.13957
Article PubMed CAS Google Scholar
Burnstock G. 2000. P2X receptors in sensory neurones. Br. J. Anaesth. 84 (4), 476–488. https://doi.org/10.1093/oxfordjournals.bja.a013473
Article PubMed CAS Google Scholar
Burnstock G. 2017. Purinergic signaling in the cardiovascular system. Circ. Res. 120 (1), 207–228. https://doi.org/10.1161/CIRCRESAHA.116.309726
Comments (0)